• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

Chemical Profile of 4-(3-tert-butylphenyl)butanal (CAS No: 62518-68-7)

4-(3-tert-butylphenyl)butanal, identified by its Chemical Abstracts Service (CAS) number 62518-68-7, is an organic compound that has garnered significant attention in the field of pharmaceutical chemistry and synthetic organic chemistry. This aldehyde derivative, characterized by its aromatic ring substituted with a tert-butyl group and a butanal moiety, exhibits unique structural and chemical properties that make it a valuable intermediate in the synthesis of various biologically active molecules.

The molecular structure of 4-(3-tert-butylphenyl)butanal consists of a phenyl ring positioned at the third position relative to a tert-butyl group, with a butanal chain extending from the fourth position. This configuration imparts steric hindrance and electronic effects that influence its reactivity and interaction with biological targets. The presence of the aldehyde group (CHO) at one end of the butanal chain makes it a versatile building block for further functionalization, enabling the construction of more complex molecules.

In recent years, 4-(3-tert-butylphenyl)butanal has been explored as a key intermediate in the development of novel therapeutic agents. Its aromatic system and substituents contribute to its ability to interact with biological macromolecules, such as proteins and enzymes, through hydrophobic and hydrogen bonding interactions. This property has been leveraged in the design of small-molecule inhibitors targeting various disease pathways.

One of the most compelling applications of 4-(3-tert-butylphenyl)butanal is in the synthesis of pharmacophores for central nervous system (CNS) disorders. Studies have demonstrated its utility in generating compounds with potential neuroprotective and anti-inflammatory properties. The tert-butyl group enhances lipophilicity, facilitating blood-brain barrier penetration, while the aldehyde functionality allows for further derivatization into amine or ester groups, which are common pharmacological moieties.

Recent advancements in medicinal chemistry have highlighted 4-(3-tert-butylphenyl)butanal as a precursor in the development of kinase inhibitors. Kinases are enzymes involved in numerous cellular processes, including signal transduction and cell proliferation, making them attractive targets for therapeutic intervention. The structural features of this compound allow for selective binding to specific kinase domains, leading to the discovery of potent and selective inhibitors with potential applications in oncology and inflammatory diseases.

The synthesis of 4-(3-tert-butylphenyl)butanal typically involves Friedel-Crafts alkylation followed by reduction steps to introduce the butanal chain. Modern synthetic methodologies have optimized these processes, improving yield and purity while minimizing environmental impact. Catalytic hydrogenation and transition-metal-catalyzed reactions have been particularly effective in achieving high selectivity and efficiency in its preparation.

From a computational chemistry perspective, 4-(3-tert-butylphenyl)butanal has been subjected to extensive molecular modeling studies to understand its interactions with biological targets. Quantum mechanical calculations have provided insights into its electronic structure, helping to rationalize its binding affinity and specificity. These computational approaches are integral in guiding experimental design and optimizing drug candidates for better pharmacokinetic profiles.

The role of 4-(3-tert-butylphenyl)butanal extends beyond pharmaceutical applications; it is also utilized in agrochemical research as a precursor for developing novel pesticides and herbicides. Its structural framework allows for modifications that enhance bioactivity against pests while maintaining environmental safety. Such applications underscore the compound's versatility as a synthetic intermediate.

In conclusion, 4-(3-tert-butylphenyl)butanal (CAS No: 62518-68-7) represents a significant compound in modern chemical research. Its unique structural attributes enable diverse applications in pharmaceuticals, agrochemicals, and materials science. Ongoing research continues to uncover new synthetic routes and biological functions, reinforcing its importance as a cornerstone molecule in medicinal chemistry.

• 7403-42-1(4-Methyl-4-phenylpentan-2-one)
• 64516-58-1(3,3-Diphenylpentanedial)
• 7775-00-0(3-[4-(propan-2-yl)phenyl]propanal)
• 18127-01-0(3-(4-tert-butylphenyl)propanal)
• 6325-41-3(3-Methyl-3-phenylbutanal)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)